| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |